Chronic liver disease not a significant comorbid condition for COVID-19

Abstract To explore the role of chronic liver disease (CLD) in COVID-19. A total 1439 consecutively hospitalized patients with COVID-19 from one large medical center United States March 16, 2020 to April 23, were retrospectively identified. Clinical characteristics and outcomes compared between without CLD. Postmortem examination 8 critically ill was performed. There no significant difference incidence CLD critical non-critical groups (4.1% vs 2.9%, p = 0.259), or related injury (65.7% 49.7%, 0.065). demonstrated mild associated central vein outflow obstruction minimal moderate portal lymphocytic infiltrate evidence Patients not a higher risk critical/fatal outcomes. comorbid condition for